Increased serum uric acid - A marker of non-gouty widespread pain? A study of female patients with inflammatory and non-inflammatory pain

Scandinavian Journal of Rheumatology

Volumn 35, Issue 4, 2006, Pages 261-267

  Andersson, H I ^a,b   Leden, I ^c  

^a KRISTIANSTAD UNIVERSITY   (Sweden)

^b Hassleholm Hospital   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC PAIN; CREATININE BLOOD LEVEL; DISABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; MUSCULOSKELETAL PAIN; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER; URIC ACID BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN; SLEEP DEPRIVATION; URIC ACID;

EID: 33746803161     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740600844779     Document Type: Article

References (22)

1. Vazquez-Mellado J, Alvarez Hernandez E, Burgos-Vargas R. Primary prevention in rheumatology: the importance of hyperuricemia. Best Pract Res Clin Rheumatol 2004;18:111-24.
2. Becker BF. Towards the physiological function of uric acid. Free Radical Biol Med 1993;14:615-31.
3. Fam AG. Gout: excess calories, purines and alcohol intake and beyond. Response to a urate-lowering diet. J Rheumatol 2005;32:773-76.
4. Waring WS, Convery AA, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci 2003;105:425-30.
5. Kanellis J, Feig DI, Johnson RJ. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed. Nephrology 2004;9:394-9.
6. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality. The NHANES I epidemiologic follow-up study, 1971-1992. J Am Med Assoc 2000;283:2404-10.
7. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional and hemodynamic staging. Circulation 2003;107:1951-3.
8. Hoskison TK, Wortmann RL. Advances in the management of gout and hyperuricaemia. Scand J Rheumatol 2006;35:251-60.
9. Aarflot T, Laerum E, Bruusgaard D. Uric acid and chronic musculoskeletal complaints. Scand J Rheumatol 1992;21:277-82.
10. Andersson HI, Ejlertsson G, Leden I, Rosenberg C. Characteristics of subjects with chronic pain, in relation to local and widespread pain report. A prospective study of symptoms, clinical findings and blood tests in subgroups of a geographically defined population. Scand J Rheumatol 1996;25:146-54.
11. Aarflot T, Bruusgaard D. Chronic musculoskeletal complaints and subgroups with special reference to uric acid. Scand J Rheumatol 1994;23:25-9.
12. Afzal N, Mahmud TE, Jahan SS, Kundi S. Uric acid profile in patients with chronic nonspecific musculoskeletal pain. J Ayub Med Coll Abbottabad 2003;15:5-9.
13. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol 2003;17:685-701.
14. Schultes B, Schmid S, Peters A, Born J, Fehm HL. Sleep loss and the development of diabetes: a review of current evidence. Exp Clin Endocrinol Diabetes 2005;113:563-7.
15. Rogers NL, Szuba MP, Staab JP, Evans DL, Dinges DF. Neuroimmunologic aspects of sleep and sleep loss. Semin Clin Neuropsychiatry 2001;6:295-307.
16. Saito H, Nishimura M, Shibuya E, Makita H, Tsujino I, Miyamoto K, et al. Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest 2002;122:1686-94.
17. Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004;164:1546-51.
18. Durak I, Kacmaz M, Cimen MY, Buyukkocak U, Ozturk HS. Blood oxidant/antioxidant status of atherosclerotic patients. Int J Cardiol 2001;77:293-7.
19. Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999;19:35-7.
20. Wood PB. Stress and dopamine: implications for the pathophysiology of chronic widespread pain. Med Hypotheses 2004;62:420-4.
21. MacFarlane GJ, McBeth J, Silman AJ. Widespread body pain and mortality: prospective population based study. Br Med J 2001;323:1-5.
22. Andersson HI. The course of non-malignant chronic pain: a 12-year follow-up of a cohort from the general population. Eur J Pain 2004;8:47-53.